- €1.61bn
- €1.89bn
- €653.76m
- 71
- 45
- 99
- 87
Annual income statement for Metrovacesa SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 146 | 511 | 519 | 586 | 654 |
| Cost of Revenue | |||||
| Gross Profit | -91.2 | 80 | 49.9 | 65.7 | 95.5 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 289 | 473 | 528 | 572 | 603 |
| Operating Profit | -143 | 37.4 | -8.46 | 14.1 | 50.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -157 | 23.7 | -18.3 | -16.5 | 24.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -164 | 18.5 | -23.5 | -20.8 | 15.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -164 | 18.5 | -23.5 | -20.8 | 15.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -164 | 18.5 | -23.5 | -20.8 | 15.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.92 | 0.104 | -0.113 | -0.1 | 0.105 |
| Dividends per Share |